{
  "abstract": "Amyotrophic lateral sclerosis (ALS) clinical trials need outcome measures that complement established end points while capturing how people function in daily life. In this viewpoint, we draw on our collective experience in ALS research, clinical trials, digital-measure development, and regulatory science, together with published evidence, a preliminary patient survey, stakeholder discussions, and experience from multisite actigraphy studies. We argue that the field now has a substantial base of longitudinal data and candidate measures, but lacks the coordinated framework needed to compare, prioritize, and validate them across studies. We identify 4 linked priorities: adopt fit-for-purpose measures in stages and within defined contexts of use; harmonize data collection and analysis; use data to shortlist and validate measures across cohorts; and prepare actigraphy methods for trial adoption through early industry and regulatory engagement. Across these priorities, actigraphy should complement rather than replace established clinical outcomes, with its integration guided by patient relevance, ALS phenotypic heterogeneity, participant, and caregiver burden, and the intended context of use. Our central message is that progress now depends less on generating additional isolated datasets or measures than on coordinating the evaluation of existing assets, and aligning future evidence generation.",
  "abstract_shown": true,
  "affiliations": [
    "UQ Centre for MND Research, School of Biomedical Sciences, The University of Queensland, Research Road, St Lucia, Brisbane, Queensland, 4072, Australia, 61 0414653551",
    "Ametris, Pensacola, FL, United States",
    "North Star ALS, Santa Barbara, CA, United States",
    "Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, England, United Kingdom",
    "Department of Neurology & Biostatistics, University Medical Center Utrecht, Utrecht, The Netherlands",
    "AGH University of Krakow, Krakow, Poland",
    "Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, United States",
    "Trace Neuroscience, South San Francisco, CA, United States",
    "Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada",
    "Department of Life Science, Manchester Metropolitan University, Manchester, England, United Kingdom",
    "Critical Path Institute, Tucson, AZ, United States",
    "ALS Therapy Development Institute, Watertown, MA, United States"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 15,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Frederik Steyn",
      "orcid": "0000-0002-4782-3608"
    },
    {
      "affs": [
        1
      ],
      "name": "Rakesh Pilkar",
      "orcid": "0000-0002-3433-9913"
    },
    {
      "affs": [
        2
      ],
      "name": "Nadia Sethi",
      "orcid": "0009-0003-0314-5993"
    },
    {
      "affs": [
        2
      ],
      "name": "Lori Heller",
      "orcid": "0009-0007-7867-3212"
    },
    {
      "affs": [
        3
      ],
      "name": "Cory Holdom",
      "orcid": "0000-0001-5972-6437"
    },
    {
      "affs": [
        4
      ],
      "name": "Ruben P A van Eijk",
      "orcid": "0000-0002-7132-5967"
    },
    {
      "affs": [
        5
      ],
      "name": "Marcin Straczkiewicz",
      "orcid": "0000-0002-8703-4451"
    },
    {
      "affs": [
        6
      ],
      "name": "Katherine M Burke",
      "orcid": "0000-0002-5820-5880"
    },
    {
      "affs": [
        6
      ],
      "name": "James D Berry",
      "orcid": "0000-0003-0898-6081"
    },
    {
      "affs": [
        7
      ],
      "name": "Sanjay Chandriani",
      "orcid": "0000-0002-8680-7424"
    },
    {
      "affs": [
        8
      ],
      "name": "Gordon Jewett",
      "orcid": "0000-0002-8268-5677"
    },
    {
      "affs": [
        9
      ],
      "name": "Emma Hodson-Tole",
      "orcid": "0000-0003-1200-1724"
    },
    {
      "affs": [
        10
      ],
      "name": "Collin Hovinga",
      "orcid": "0009-0003-1447-029X"
    },
    {
      "affs": [
        11
      ],
      "name": "Fernando Vieira",
      "orcid": "0000-0003-2996-6418"
    },
    {
      "affs": [
        1
      ],
      "name": "Christine Guo",
      "orcid": "0000-0003-1530-0172"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/dnz2ne9jw37r9.bib",
  "cited_by": 0,
  "doi": "10.2196/106677",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13759183/",
  "id": "dnz2ne9jw37r9",
  "issns": [
    "1439-4456",
    "1438-8871"
  ],
  "landing_url": "https://doi.org/10.2196/106677",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Participatory Medicine & E-Patients"
    ],
    [
      "heading",
      "Patient-Centred Outcomes Research"
    ],
    [
      "heading",
      "Viewpoint"
    ],
    [
      "heading",
      "Viewpoints and Perspectives"
    ],
    [
      "heading",
      "Wearable Devices and Sensors"
    ],
    [
      "heading",
      "mHealth for Symptom and Disease Monitoring, Chronic Disease Management"
    ],
    [
      "openalex",
      "2728|Amyotrophic Lateral Sclerosis Research"
    ]
  ],
  "openalex": "W7212268475",
  "pdf_url": null,
  "pmcid": "PMC13759183",
  "pmid": "43019526",
  "published": "2026-11-12",
  "publisher": "JMIR Publications Inc.",
  "ris": "https://research.draconitic.com/paper/dnz2ne9jw37r9.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:47Z",
      "native_id": "PMC13759183",
      "source": "pmc",
      "url": "https://doi.org/10.2196/106677"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2728|Amyotrophic Lateral Sclerosis Research",
      "subfield": "neurology"
    }
  ],
  "title": "Rethinking Digital Outcome Measures for Amyotrophic Lateral Sclerosis Trials: Consensus Priorities for Actigraphy Harmonization, Validation, and Regulatory Readiness",
  "title_text": "Rethinking Digital Outcome Measures for Amyotrophic Lateral Sclerosis Trials: Consensus Priorities for Actigraphy Harmonization, Validation, and Regulatory Readiness",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:47Z",
  "url": "https://research.draconitic.com/paper/dnz2ne9jw37r9",
  "venue": "Journal of Medical Internet Research",
  "versions": []
}